MENU
The Office of Pharmaceutical Industry Research
  • Guide Map
  • Japanese
  • Institute Overview
  • Position Papers
  • OPIR Views and Actions
  • Research Papers
  • Research Group Reports
  • JPMA website
Close
The Office of Pharmaceutical Industry Research

Return to Site Top

  • Institute Overview
  • Research Themes
  • Position Papers
  • OPIR Views and Actions
  • Research Papers
  • Research Group Reports
  • JPMA website Page will open in a new window.
  • Guide Map
  • Japanese
  • Position Papers

    Click here for published materials

  • OPIR Views and Actions

    Click here for the latest issue

  • Research Papers

    Click here for the latest issue

  • Industry Research Database

    For member companies only

What's New

  • July 2, 2026
    New

    OPIR Views and Actions Issue No. 78 has been posted.

     
  • Jun 05, 2026
    new

    We have updated the institute overview.

     
  • Mar 31, 2026.

    Position Paper "Japanese Patient-Reported Outcome (PRO) Compendium - The Actual State of Phase III Clinical Trials" is now available.

     

List of New Arrivals

Pick Up

OPIR Views and Actions Issue No. 78 has been posted.

OPIR Views and Actions Click here for the summary of No. 78

This issue includes the following

  • Development Status of Pharmaceuticals for Unmet Medical Needs

    The Office of Pharmaceutical Industry Research Principal Researcher Takuro Utsumi
    The Office of Pharmaceutical Industry Research; Senior Researcher Shinji Tsubakihara

  • Japan’s Prescription Drug Market from the Perspective of the Yen and the Dollar

    The Office of Pharmaceutical Industry Research  Principal Daisuke Kanai
    The Office of Pharmaceutical Industry Research; Senior Researcher Shinji Tsubakihara
    The Office of Pharmaceutical Industry Research; Principal Researcher Ryusuke Nabeshima

  • Utilization of Patient-Reported Outcome Measure (PROM) Data in OECD Member Countries: Insights from an OECD Report

    The Office of Pharmaceutical Industry Research; Senior Researcher Shinji Tsubakihara
    The Office of Pharmaceutical Industry Research; Principal Researcher Ryusuke Nabeshima
    The Office of Pharmaceutical Industry Research; Principal Researcher Saori Kamiji

  • An Exploratory Study on the Effects and Challenges of AI Utilization in Recent Clinical Development —Subject Recruitment and Clinical Trial Documentation—

    The Office of Pharmaceutical Industry Research  Principal Researcher Makoto Edahiro
    The Office of Pharmaceutical Industry Research Principal Researcher Sho Hibino
    The Office of Pharmaceutical Industry Research Principal Researcher Kohei Shimoyamada

  • Institute Overview
  • Research Themes
  • Position Papers
  • OPIR Views and Actions
  • Research Papers
  • Research Group Reports
  •  Subscribe to Newsletter

Go to top of page

  • Research Institute Overview
  • Research Themes
  • Position Papers
  • OPIR Views and Actions
  • Research Papers
  • Research Group Reports
  • Site Map
  • Privacy Policy Page will open in a new window.
  • Social Media Policy Page will open in a new window.
  • JapanesePage will open in a new window.
  • X
  •  facebook
  •  youtube

© Office of Pharmaceutical Industry Research(OPIR). All rights reserved.

Notification

This website uses automatic translation.
The translated content may not always be fully consistent with the original Japanese content.